[ad_1]
Reuters
Potential “Pfizer & Biontech” vaccine against Corona – archive
U.S. media sources have confirmed that Pfizer will produce around 50 million doses of its Corona vaccine by the end of 2020, instead of 100 million doses due to supply issues with necessary materials.
The American Wall Street Journal quoted an informed source as saying, “We were late. Some shipments of materials, in fact, were not up to our standards … We have fixed this problem, but we will not. time to meet this year’s procurement plan. “
“In this case, everything was done at the same time,” he said. “We started working on the components supply chain last March when vaccine development was not complete. It’s totally unprecedented.”
The newspaper pointed out that companies usually develop the vaccine first and obtain authorization for use, then arrange to supply everything needed for production, but in the case of “Covid-19” everything had to be done. in a very short time and prepare for mass production, Without waiting for the vaccine to be developed.
The American “Pfizer” has developed a vaccine in partnership with German “BioNtech”, and the drug has been approved for use in Great Britain, and it is expected that it will soon obtain approval in the European Union and in the USA.
Source: “Interfax”
[ad_2]
Source link
